Cometriq

Update news Cometriq

U.S. FDA approves new medication to treat rare type of thyroid cancer

The U.S. Food and Drug Administration (FDA) on Thursday approved Cometriq to treat medullary thyroid cancer that has spread to other parts of the body.

U.S. FDA approves new medication to treat rare type of thyroid cancer

 The U.S. Food and Drug Administration (FDA) on Thursday approved Cometriq to treat medullary thyroid cancer that has spread to other parts of the body.